Seligson & Co Rahastoyhtiö Oyj
29.1.2026 18:06:56 CET | Globenewswire | Press release
SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: PROPOSAL FOR RULE CHANGE
SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: PROPOSAL FOR RULE CHANGE
Seligson & Co Fund Management Company Plc
STOCK EXCHANGE RELEASE 29 JANUARY 2026
SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: PROPOSAL FOR RULE CHANGE
On 29 January 2026, the Board of Directors of Seligson & Co Fund Management Company Plc has decided to change the rules of the Seligson & Co OMXH25 exchange traded fund.
Provisions corresponding to the new regulation are added to the rules to ensure the liquidity of the fund. The changes will not affect the fund's investment policy, risk profile, fees, or nature. The aim of the rule change is to improve the fund's risk management and investor protection. The changes do not require any action on the part of the unitholders.
Approval for the rule change will be sought from the Finnish Financial Supervisory Authority.
Further information: Mari Rautanen, email: mari.rautanen@seligson.fi, phone: +358 (0)9 6817 8224
Seligson & Co Fund Management Company Plc
Aleksi Härmä
Managing Director
email: aleksi.harma@seligson.fi
phone: +358 (0)9 6817 8235
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Trifork Group AG26.8.2026 17:43:32 CEST | Press release
51/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Scandinavian Tobacco Group A/S26.8.2026 17:20:00 CEST | Press release
Scandinavian Tobacco Group: Interim Report 1 January – 30 June 2026: Progressing with Focus2030 and Full Year 2026 Guidance maintained
Aegon Ltd.26.8.2026 15:50:00 CEST | Press release
Aegon has filed Shareholder Circular for proposed US redomiciliation
ODDIFACT26.8.2026 15:27:59 CEST | Press release
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Værdipapirfonden Independent Invest II26.8.2026 15:03:40 CEST | Pressemeddelelse
Fusion af afdelinger i Værdipapirfonden Independent Invest II
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom